Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 6

1.

Human type 1 diabetes is associated with T cell autoimmunity to zinc transporter 8.

Dang M, Rockell J, Wagner R, Wenzlau JM, Yu L, Hutton JC, Gottlieb PA, Davidson HW.

J Immunol. 2011 May 15;186(10):6056-63. doi: 10.4049/jimmunol.1003815. Epub 2011 Apr 6.

2.

Autoimmune mechanisms in type 1 diabetes.

Knip M, Siljander H.

Autoimmun Rev. 2008 Jul;7(7):550-7. doi: 10.1016/j.autrev.2008.04.008. Epub 2008 Apr 30. Review.

PMID:
18625444
3.

New antigenic targets in type 1 diabetes.

Wenzlau JM, Hutton JC, Davidson HW.

Curr Opin Endocrinol Diabetes Obes. 2008 Aug;15(4):315-20. doi: 10.1097/MED.0b013e328308192b. Review.

PMID:
18594270
4.

Current and Future Clinical Applications of Zinc Transporter-8 in Type 1 Diabetes Mellitus.

Yi B, Huang G, Zhou ZG.

Chin Med J (Engl). 2015 Sep 5;128(17):2387-94. doi: 10.4103/0366-6999.163389. Review.

5.

Different role of zinc transporter 8 between type 1 diabetes mellitus and type 2 diabetes mellitus.

Yi B, Huang G, Zhou Z.

J Diabetes Investig. 2016 Jul;7(4):459-65. doi: 10.1111/jdi.12441. Epub 2016 Jan 9. Review.

6.

T-cell Metabolism as a Target to Control Autoreactive T Cells in β-Cell Autoimmunity.

Bordignon C, Canu A, Dyczko A, Leone S, Monti P.

Curr Diab Rep. 2017 May;17(5):24. doi: 10.1007/s11892-017-0848-5. Review.

Supplemental Content

Support Center